Attached files

file filename
EX-23.1 - EX-23.1 - SteadyMed Ltd.a14-20867_11ex23d1.htm
EX-5.1 - EX-5.1 - SteadyMed Ltd.a14-20867_11ex5d1.htm

 

As filed with the Securities and Exchange Commission on March 19, 2015.

Registration No. 333-           

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

Form S-1

REGISTRATION STATEMENT

UNDER THE SECURITIES ACT OF 1933

 


 

SteadyMed Ltd.

(Exact name of registrant as specified in its charter)

 

Israel
(State or other jurisdiction of
incorporation or organization)

 

2834
(Primary Standard Industrial
Classification Code Number)

 

Not Applicable
(I.R.S. Employer
Identification Number)

 

SteadyMed Ltd.

5 Oppenheimer Street

Rehovot 7670105, Israel

+972-3-6449556

(Address, including zip code, and telephone number,

including area code, of registrant’s principal executive offices)

 

Jonathan M.N. Rigby

President and Chief Executive Officer

SteadyMed Therapeutics, Inc.

2410 Camino Ramon

San Ramon, California 94583

(925) 272-4999

(Name, address, including zip code, and telephone number,

including area code, of agent for service)

 

Copies to:

 

James C. Kitch
Michael E. Tenta
Cooley LLP
3175 Hanover
Street
Palo Alto, CA
94304
(650) 843-5000

Einat Katzenell
Diana Zatuchna
Katzenell Dimant Frank
89 Medinat Hayehudim
St.
Herzeliya Business Park
Building E, 9th Floor
Herzeliya Pituach 4614001
Israel

Shlomo Landress
Amit, Pollak, Matalon & Co.
17 Yitzhak Sade, Nizba
Building
Tel Aviv 6777517
Israel

Cheryl V. Reicin
Mile T. Kurta
Torys LLP
1114 Avenue of the Americas,
23rd Floor
New York, New York 10036
(212) 880-6000

Chaim Friedland, Adv.
Ari Fried, Adv.
Gornitzky & Co.
Zion House
45 Rothschild Blvd.
Tel Aviv 6578403, Israel
+972-3-710-9191

 


 

Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this Registration Statement.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. o

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. x 333-201949

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer o

Accelerated filer o

Non-accelerated filer x
(Do not check if a
smaller reporting company)

Smaller reporting company o

 

CALCULATION OF REGISTRATION FEE

 

Title of Each Class of Securities
to be Registered

 

 

Number of Shares
to be Registered(1)

 

 

Proposed Maximum
Offering Price
Per Share(2)

 

 

Proposed Maximum
Aggregate Offering
Price

 

 

Amount of
Registration Fee

 

Ordinary shares, nominal value NIS 0.01 per share

 

 

517,500

 

 

$

8.50

 

 

$

4,398,750

 

 

$

511.14

 

(1)                                 The ordinary shares being registered pursuant to this Registration Statement are in addition to the 4,887,500 ordinary shares registered pursuant to the Registrant’s Registration Statement on Form S-1 (Registration No. 333-201949).

(2)                                 Based on the initial public offering price.

 

 

 



 

EXPLANATORY NOTE AND INCORPORATION OF CERTAIN INFORMATION BY REFERENCE

 

This Registration Statement on Form S-1 is being filed with the Securities and Exchange Commission (the “Commission”) pursuant to Rule 462(b) under the Securities Act of 1933, as amended. This Registration Statement incorporates by reference the contents of, including all amendments and exhibits thereto and all information incorporated by reference therein, the Registration Statement on Form S-1 (Registration No. 333-201949), which was declared effective by the Commission on March 19, 2015, and is being filed solely for the purpose of registering an increase in the amount of ordinary shares registered by 517,500 shares. The required opinions and consents are listed on the Exhibit Index attached hereto.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Ramon, California on March 19, 2015.

 

 

STEADYMED LTD.

 

 

 

 

 

By:

/s/ JONATHAN M.N. RIGBY

 

 

Name: Jonathan M.N. Rigby
Title: President and Chief Executive Officer

 

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated:

 

Signature

 

Title

 

Date

 

 

 

 

 

 

 

 

 

 

 

 

President and Chief Executive Office

 

March 19, 2015

/s/ JONATHAN M.N. RIGBY

 

(Principal Executive Officer) and

 

Jonathan M.N. Rigby

 

Authorized Representative in the

 

 

 

United States

 

 

 

 

 

 

 

 

 

 

 

/s/ DAVID W. NASSIF

 

Chief Financial Officer

 

March 19, 2015

David W. Nassif

 

(Principal Financial and Accounting Officer)

 

 

 

 

 

 

*

 

Director

 

March 19, 2015

Keith Bank

 

 

 

 

 

 

*

 

Director

 

March 19, 2015

Stephen J. Farr

 

 

 

 

 

 

*

 

Director

 

March 19, 2015

Ron Ginor

 

 

 

 

 

 

 

 

Director

 

 

Donald D. Huffman

 

 

 

 

 

 

*

 

Director

 

March 19, 2015

Brian J. Stark

 

 

 

 

 

 

*

 

Director

 

March 19, 2015

William S. Slattery

 

 

 

 

 

 

*By:

/s/ JONATHAN M.N. RIGBY

 

 

 

 

 

Attorney-in-fact

 

 

 

 

 

3



 

EXHIBIT INDEX

 

Exhibit

 

 

 

Incorporated by Reference

 

Number

 

Exhibit Description

 

Form

 

File No.

 

Exhibit

 

Filing Date

 

 

 

 

 

 

 

 

 

 

 

 

 

5.1

 

Opinion of Amit, Pollak, Matalon & Co.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

23.1

 

Consent of Independent Registered Public Accounting Firm

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

23.2

 

Consent of Amit, Pollak, Matalon & Co. (included in Exhibit 5.1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

24.1

 

Power of Attorney

 

S-1

 

333-201949

 

Included on signature page

 

February 6, 2015

 

 

4